News & Updates

First-line NALIRIFOX regimen ups survival in metastatic pancreatic cancer

The use of liposomal irinotecan in combination with 5-fluorouracil, leucovorin, and oxaliplatin (NALIRIFOX regimen) significantly improved overall survival (OS) and progression-free survival (PFS) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) compared with gemcitabine plus nab-paclitaxel (Gem+NabP) in the first-line setting, according to the NAPOLI-3* trial presented at the ASCO GI 2023.

Hyaluronic acid rectal spacer improves safety outcomes of hypofractionated RT for prostate cancer

Rectal spacing with hyaluronic acid helps lessen rectal dosimetry and mitigate the gastrointestinal (GI) toxicity associated with hypofractionated radiation therapy (RT) for prostate cancer, according to a study.

IV iron for chemo-induced anaemia: Ready for primetime?

Intravenous (IV) iron reduces the need for red blood cell (RBC) transfusions in patients with chemotherapy-induced anaemia (CIA), without any difference in adverse events (AEs), compared with oral iron or placebo in a new study.

Is first-line lazertinib monotherapy a potential new SoC for EGFRm NSCLC?

NPC: Plasma EBV DNA cannot replace nasoendoscopy and biopsy during COVID-19 pandemic

Plasma Epstein-Barr virus (EBV) measurement, even when supplemented by imaging, cannot replace nasoendoscopy and biopsy in nasopharyngeal cancer (NPC) management during the COVID-19 pandemic, according to consensus recommendations by an international multidisciplinary group of experts.

Blinatumomab-chemo boosts survival in MRD-negative B-lineage ALL

The addition of blinatumomab to chemotherapy extended overall survival (OS) in adults with measurable residual disease (MRD)-negative B-lineage acute lymphoblastic leukaemia (ALL), according to results of the phase III ECOG-ACRIN E1910 trial.

Early rehab makes a difference for children with cancer

Participating in an individualized rehabilitation program is beneficial to children with cancer, yielding significant gains in function without any adverse consequences, as reported in a study from Singapore.